Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS)

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 12, 2012, Pages 1480-1487

  Lindfors, Perjohan ^a,c   Törnblom, Hans ^a,b   Sadik, Riadh ^a   Björnsson, Einar S ^a   Abrahamsson, Hasse ^a   Simrén, Magnus ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Sabbatsberg Hospital   (Sweden)

Author keywords

Gut directed hypnotherapy; Irritable bowel syndrome; Manometry; Transit investigation

Indexed keywords

ADULT; ANTRODUODENOJEJUNAL MANOMETRY; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; GUT DIRECTED HYPNOTHERAPY; HUMAN; HYPNOSIS; INTESTINE TRANSIT TIME; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MANOMETRY; MOTOR PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; TREATMENT DURATION;

ADULT; CHI-SQUARE DISTRIBUTION; DUODENUM; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; JEJUNUM; MALE; MANOMETRY; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 84870016089     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.733955     Document Type: Article

References (46)

1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-21; e4.
2. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-85. (Pubitemid 34680762)
3. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007;102:2767-76. (Pubitemid 350179350)
4. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
5. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-41.
6. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80. (Pubitemid 23271409)
7. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-47. (Pubitemid 30490414)
8. Lindfors P, Unge P, Arvidsson P, Nyhlin H, Bjornsson E, AbrahamssonH, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 2012;107:276-85.
9. Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol 2011;106:1481-91.
10. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable- bowel syndrome. Lancet 1984;2:1232-4. (Pubitemid 15217715)
11. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987;28:423-5. (Pubitemid 17056876)
12. Svedlund J, Sjodin I, Ottosson JO, Dotevall G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983;2:589-92. (Pubitemid 13051045)
13. Blanchard EB, Greene B, Scharff L, Schwarz-McMorris SP. Relaxation training as a treatment for irritable bowel syndrome. Biofeedback Self Regul 1993;18:125-32.
14. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002;97:954-61. (Pubitemid 34408254)
15. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-9. (Pubitemid 37363448)
16. Simren M. Hypnosis for irritable bowel syndrome: the quest for the mechanism of action. Int J Clin Exp Hypn 2006;54:65-84. (Pubitemid 41769755)
17. McKee DP, Quigley EM. Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. Dig Dis Sci 1993;38:1761-72. (Pubitemid 23311925)
18. McKee DP, Quigley EM. Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder. Dig Dis Sci 1993;38:1773-82. (Pubitemid 23311926)
19. Narducci F, Bassotti G, Granata MT, Pelli MA, Gaburri M, Palumbo R, et al. Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci 1986;31:241-6. (Pubitemid 16123968)
20. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 1988;94:1150-6.
21. Welgan P, Meshkinpour H, Hoehler F. The effect of stress on colon motor and electrical activity in irritable bowel syndrome. Psychosom Med 1985;47:139-49. (Pubitemid 15108847)
22. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
23. Posserud I, Syrous A, Lindstrom L, Tack J, Abrahamsson H, Simren M. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007;133:1113-23. (Pubitemid 47494459)
24. Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990;31:896-8. (Pubitemid 20269538)
25. Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:635-42. (Pubitemid 36418886)
26. Simrén M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004;66:233-8. (Pubitemid 38393232)
27. Palsson OS, Turner MJ, Johnson DA, Burnett CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47:2605-14. (Pubitemid 35305474)
28. Whorwell PJ, Houghton LA, Taylor EE, Maxton DG. Physiological effects of emotion: assessment via hypnosis. Lancet 1992;340:69-72.
29. Beaugerie L, Burger AJ, Cadranel JF, Lamy P, Gendre JP, Le Quintrec Y. Modulation of orocaecal transit time by hypnosis. Gut 1991;32:393-4.
30. Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol 2003;38:36-42. (Pubitemid 36152862)
31. Sadik R, Stotzer PO, Simren M, Abrahamsson H. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil 2008;20:197-205. (Pubitemid 351197397)
32. Simren M, Castedal M, Svedlund J, Abrahamsson H, Bjornsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS). Dig Dis Sci 2000;45:2151-61. (Pubitemid 32060385)
33. ThompsonWG, LongstrethGF, DrossmanDA,Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45:II43-7. (Pubitemid 29434812)
34. Gonsalkorale WM. Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome. Int J Clin Exp Hypn 2006;54:27-50. (Pubitemid 41769753)
35. Stotzer PO, Abrahamsson H. Human postprandial gastric emptying of indigestible solids can occur unrelated to antral phase III. Neurogastroenterol Motil 2000;12:415-19.
36. Stanghellini V, Camilleri M, Malagelada Jr. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987;28:5-12. (Pubitemid 17231539)
37. Wingate D, Hongo M, Kellow J, Lindberg G, Smout A. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002;17(Suppl):S1-14.
38. Webb AN, Kukuruzovic RH, Catto-Smith AG, Sawyer SM. Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2007;CD005110.
39. Hernando-Harder AC, Serra J, Azpiroz F, Mila M, Aguade S, Malagelada C, et al. Colonic responses to gas loads in subgroups of patients with abdominal bloating. Am J Gastroenterol 2010;105:876-82.
40. Salvioli B, Serra J, Azpiroz F, Malagelada Jr. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol 2006;101:1853-7. (Pubitemid 44166597)
41. Tremolaterra F, Villoria A, Serra J, Azpiroz F, Malagelada Jr. Intestinal tone and gas motion. Neurogastroenterol Motil 2006;18:905-10. (Pubitemid 44358860)
42. Simren M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001;48:20-7. (Pubitemid 32042637)
43. Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63:108-15. (Pubitemid 32221204)
44. Tornblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simren M. Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol 2012;107:754-60.
45. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29-34. (Pubitemid 40204009)
46. Vlieger AM, van den Berg MM, Menko-Frankenhuis C, Bongers ME, Tromp E, Benninga MA. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2010;105:213-18.